The RGAG1 Polyclonal Antibody (PAC021898) is designed for research involving RGAG1, a protein associated with immune regulation and cell signaling. The antibody, generated in rabbits, exhibits high specificity and sensitivity when detecting RGAG1 in human samples, making it suitable for use in Western blot applications. By targeting the RGAG1 protein, this antibody enables the visualization and analysis of RGAG1 expression in various cell types, offering valuable insights for studies in immunology and cancer research.
RGAG1, also referred to as a modulator of immune response, plays a crucial role in regulating immune cell function and influencing inflammatory processes. Its involvement in immune modulation highlights its potential as a therapeutic target for diseases such as cancer, autoimmune disorders, and chronic inflammation. Investigating the function of RGAG1 is essential for designing treatments that modulate immune responses and combat disease progression in these pathological conditions.
Antibody Name:
RGAG1 Antibody (PACO21898)
Antibody SKU:
PACO21898
Size:
100ul
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:3000
Species Reactivity:
Human, Mouse
Immunogen:
Synthesized peptide derived from C-terminal of human RGAG1.
Form:
Liquid
Storage Buffer:
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Western blot analysis of extracts from COLO cells, using RGAG1 antibody.
Background:
Nagase T., DNA Res. 7:65-73(2000).
Synonyms:
Retrotransposon gag domain-containing protein 1; BJ-HCC-23 tumor antigen; RGAG1; KIAA1318;
